New brand drug - Otulfi (ustekinumab-aauz)

Otulfi (ustekinumab-aauz) - indicated for 1) moderate-severe plaque psoriasis in adult and pediatric patients, 2) psoriatic arthritis in adult and pediatric patients, 3) moderate-severe Crohn disease in adult patients, and 4) moderate-severe ulcerative colitis in adult patients.